What Is Peritoneal Mesothelioma?
Peritoneal mesothelioma is a rare, aggressive cancer that develops in the peritoneum, the thin membrane that lines the abdomen and covers many of the abdominal organs. The disease usually develops after an individual swallows or inhales asbestos fibers, which then travels from the lungs to the abdomen.
In the peritoneum, asbestos fibers can remain for decades before causing inflammation that may eventually lead to cancer. Peritoneal mesothelioma accounts for about 15% to 20% of all mesothelioma cases, making it the second-most-common type after pleural mesothelioma, which affects the lining around the lungs.
Many individuals with peritoneal mesothelioma first notice symptoms such as abdominal pain, swelling, bloating or unexplained weight loss. Because these symptoms are common to many other conditions, doctors often don’t diagnose the disease until performing imaging tests and a biopsy.
Peritoneal mesothelioma is a serious disease, but treatment has improved significantly in recent years. For eligible patients, cytoreductive surgery combined with heated chemotherapy has helped many people live longer and achieve better outcomes. Researchers also continue to study new chemotherapy, immunotherapy and other treatment options, giving patients and families more hope than ever before.
Pleural vs. Peritoneal Mesothelioma (and Other Abdominal Cancers)
Peritoneal and pleural mesothelioma are both rare cancers caused primarily by asbestos exposure. However, they develop in different parts of the body and have different diagnoses, staging systems and treatments. Peritoneal mesothelioma forms in the lining of the abdomen, while pleural mesothelioma develops in the lining around the lungs.
Peritoneal mesothelioma can also resemble other abdominal cancers, including ovarian cancer, colorectal cancer and peritoneal carcinomatosis. These diseases often cause similar symptoms such as abdominal pain, bloating and fluid buildup (ascites). Because imaging tests alone usually can’t confirm the diagnosis, doctors often perform a biopsy and immunohistochemical testing to distinguish peritoneal mesothelioma from these other diseases.
Table 1. Comparison of Peritoneal and Pleural Mesothelioma
| Feature | Peritoneal Mesothelioma | Pleural Mesothelioma |
| Location | Lining of the abdomen (peritoneum) | Lining around the lungs (pleura) |
| Share of cases | ~15%-20% | ~80% |
| Staging system | Peritoneal Cancer Index | TNM Classification |
| Signature treatment | Cytoreductive surgery with heated chemotherapy for eligible patients | Surgery, chemotherapy, immunotherapy and, in some cases, radiation therapy |
| Typical prognosis | Often more favorable for patients treated with CRS and HIPEC | Generally less optimistic |
Symptoms of Peritoneal Mesothelioma
Peritoneal mesothelioma symptoms usually affect the abdomen and are often vague in the early disease stages. Because these symptoms overlap with many common digestive conditions, doctors often have delayed diagnoses. Many people first undergo imaging tests for unexplained abdominal pain, swelling or bloating before additional testing leads to a peritoneal mesothelioma diagnosis.
Early vs. Advanced Symptoms
Early Symptoms
- Abdominal distension or swelling caused by fluid buildup (ascites)
- Abdominal pain or cramping
- Bloating or feeling full quickly
- Fatigue and weakness
- Nausea, vomiting or changes in bowel habits, including constipation or diarrhea
- Unexplained weight loss and loss of appetite
Advanced Symptoms
- Bowel obstruction, possibly causing severe abdominal swelling, persistent vomiting, constipation and an inability to pass gas or stool
- Large or recurrent ascites
- Persistent or severe abdominal pain
- Progressive weight loss and malnutrition
These symptoms aren’t unique to peritoneal mesothelioma and can resemble ovarian cancer, colorectal cancer and other abdominal conditions. Doctors usually confirm the diagnosis with imaging tests followed by a biopsy and immunohistochemical testing.
What Causes Peritoneal Mesothelioma?
Asbestos exposure is the main known cause of peritoneal mesothelioma. In most cases, people experience exposure to asbestos many years before developing this rare cancer.
Researchers believe that swallowed asbestos fibers, or fibers cleared from the lungs and carried to the abdomen, can lodge themselves in the peritoneum. Over time, these fibers can cause chronic inflammation and cell damage. After a long latency period, typically 20 to 50 years or more, these changes may eventually lead to peritoneal mesothelioma.
Not everyone with peritoneal mesothelioma has a known history of asbestos exposure. Compared with pleural mesothelioma, the link between asbestos and peritoneal mesothelioma is less exclusive. Researchers continue to study why some people develop the disease without an identifiable asbestos exposure.
How Do People Receive Asbestos Exposure?
People diagnosed with mesothelioma may receive exposure to asbestos in several ways. Occupational exposure has occurred in industries such as construction, shipbuilding, insulation, mining and manufacturing. Secondary exposure can happen when a worker carries home asbestos fibers on their clothing, shoes or equipment and unintentionally exposes family members. Environmental exposure may occur when people live near naturally occurring asbestos deposits or former industrial sites with asbestos contamination.
If you were exposed to asbestos and have been diagnosed with peritoneal mesothelioma, you may have legal options. Individuals diagnosed with asbestos-related mesothelioma may be eligible to pursue compensation from the manufacturers or suppliers of the asbestos-containing products responsible for their exposure.
How Do Doctors Diagnose Peritoneal Mesothelioma?
Diagnosing peritoneal mesothelioma usually involves several steps because its symptoms often resemble other, more common abdominal conditions. No single blood test or imaging study can confirm the disease, and only a tissue biopsy with specialized laboratory testing can make a definitive diagnosis.
Diagnosing Peritoneal Mesothelioma
1. Imaging tests: Doctors usually start with a CT scan to look for abdominal masses, ascites, thickening of the peritoneum and other signs of disease. An MRI or PET scan may help determine how far the cancer has spread and guide treatment planning.
2. Blood biomarkers: Testing biomarkers such as mesothelin, fibulin-3 and CA-125 may provide supporting information, but it can’t diagnose peritoneal mesothelioma on its own.
3. Biopsy and immunohistochemistry: A tissue biopsy is the gold standard for diagnosing peritoneal mesothelioma. Doctors examine the tissue under a microscope and use immunohistochemical staining to confirm the diagnosis and determine the mesothelioma cell type.
4. Diagnostic laparoscopy: In many cases, surgeons perform a minimally invasive procedure to examine the abdominal cavity, obtain biopsy samples and assess the extent of disease. This evaluation helps calculate the Peritoneal Cancer Index, an important tool that determines whether CRS and HIPEC are appropriate treatment options.
Peritoneal mesothelioma is uncommon, and doctors can mistake it for ovarian cancer, colorectal cancer or other abdominal diseases. To reduce the risk of misdiagnosis and make sure they receive the most appropriate treatments, you should seek an evaluation at a specialized mesothelioma center with expertise in diagnosing and treating this rare cancer.
Mesothelioma Stages in the Peritoneal Cancer Index
Unlike pleural mesothelioma, doctors usually don’t stage peritoneal mesothelioma with the TNM Classification, the most commonly used staging system. Instead, doctors most often use the Peritoneal Cancer Index to measure how far the cancer has spread throughout the abdomen. The PCI helps estimate the extent of disease and determine whether the individual is eligible for CRS with HIPEC.
The PCI assigns a score from 0 to 39 by evaluating the size and location of tumors in 13 abdominal regions. In general, a lower PCI score means the cancer is less extensive, and surgery is more likely to remove all visible disease. A higher PCI score indicates more widespread cancer, but it doesn’t automatically mean surgery or other treatments are impossible. Before recommending treatment, doctors also consider your overall health, mesothelioma cell type and whether it seems possible to completely remove the tumor.
The TNM Classification is more familiar to most people, with its classic Stage I-IV system. However, there’s no such thing as “Stage 4 peritoneal mesothelioma.” Instead, specialists rely on the PCI because it provides a more accurate assessment of disease throughout the abdominal cavity.
Even if you have a high PCI score or advanced disease, effective treatment options may still be available. Depending on your individual situation, these may include CRS with HIPEC, systemic chemotherapy, immunotherapy, supportive care or participation in a clinical trial. An experienced mesothelioma team can evaluate you and determine the best treatment plan for your unique circumstances.
Cell Types: Epithelioid, Sarcomatoid, Biphasic
Peritoneal mesothelioma has three main cell types, called epithelioid, sarcomatoid and biphasic. A biopsy can determine your cell type, which is one of the most important factors doctors use to estimate your prognosis and decide whether treatments such as CRS with HIPEC may be beneficial.
- Epithelioid: The most common cell type. It usually responds best to treatment and has the most favorable prognosis.
- Sarcomatoid: The rarest and most aggressive cell type. It’s generally more difficult to treat and has the poorest prognosis.
- Biphasic: A combination of epithelioid and sarcomatoid cells.
Prognosis depends on the proportion of each cell type. Tumors containing more epithelioid cells typically have better outcomes than those with predominantly sarcomatoid cells. Knowing your mesothelioma cell type helps your medical team recommend the most appropriate treatment and provide a more individualized outlook.
Treatment for Peritoneal Mesothelioma
Peritoneal mesothelioma treatments have improved significantly over the past two decades. Today, many patients have better outcomes than in the past, especially those eligible for CRS with HIPEC. This treatment combination has given many individuals with peritoneal mesothelioma a more favorable prognosis than those with pleural mesothelioma.
Cytoreductive Surgery with Heated Chemotherapy
For eligible patients, CRS combined with HIPEC is the standard treatment for peritoneal mesothelioma. During CRS, surgeons remove all visible tumors from the abdomen. Immediately afterward, heated chemotherapy circulates throughout the abdominal cavity to destroy microscopic cancer cells that may remain after surgery.
Not everyone is a candidate for CRS and HIPEC. Doctors consider several factors, including whether they can completely remove the tumor, along with the individual’s overall health, PCI score and mesothelioma cell type. People with epithelioid mesothelioma and less extensive disease generally have the best outcomes. In carefully selected patients, studies have reported 5-year survival rates approaching 75% after completing CRS and HIPEC.
Other Treatment Options
Treatment eligibility is different for every patient. If CRS and HIPEC aren’t appropriate, other treatments are available.
- Systemic chemotherapy: A combination of cisplatin and pemetrexed is the standard chemotherapy for many patients with advanced or unresectable peritoneal mesothelioma.
- Immunotherapy: Doctors may recommend checkpoint inhibitors such as Opdivo (nivolumab) and Yervoy (ipilimumab) for some individuals, although research specific to peritoneal mesothelioma is still evolving.
- Radiation therapy: Radiation has a limited role because peritoneal mesothelioma usually affects multiple areas of the abdomen. Doctors may use it to relieve symptoms or treat specific areas of disease.
- Palliative and supportive care: Treatments to control ascites, relieve pain, improve nutrition and manage bowel obstruction can help maintain quality of life throughout treatment.
- Clinical trials: Clinical trials evaluate new immunotherapies, targeted therapies and other promising treatments that may expand future treatment options.
A mesothelioma specialist can determine which treatments are the best option for your individual situation. A consultation at a mesothelioma center is a smart first step.
Get a Free ConsultationPrognosis and Survival Rate
Experts base survival statistics on groups of patients and can’t predict exactly how long any one person will live. Several factors influence prognosis. Patients with epithelioid mesothelioma, lower PCI scores and completely removable tumors have the best long-term outcomes. Earlier diagnosis, younger age, good overall health and fewer medical conditions also affect survival rates.
Table 2. Reported Survival Outcomes for Peritoneal Mesothelioma
| Clinical Scenario | Reported Survival |
| Median life expectancy with general treatment | ~31-92 months |
| Median life expectancy without treatment | ~12 months |
| Eligible patients treated with CRS and HIPEC | ~70% 5-year survival |
Compensation for Peritoneal Mesothelioma
If asbestos exposure caused your peritoneal mesothelioma, you may be eligible to seek financial compensation. Attorneys generally base claims on your diagnosis and asbestos exposure history. In most cases, lawyers file lawsuits against the companies that made or sold asbestos-containing products, not against your employer. Most mesothelioma law firms also work on a contingency-fee basis, meaning you pay no legal fees unless they recover compensation.
Compensation may help cover medical expenses, including CRS and HIPEC, along with lost wages, pain and suffering, travel expenses for treatment and, in some cases, wrongful death damages. Depending on your situation, you may qualify for mesothelioma compensation through a lawsuit, asbestos trust fund claim or other legal options.
Many people don’t know exactly when or where they received asbestos exposure. Our experienced mesothelioma attorneys can investigate your work history, military service, product exposure and other records to identify the responsible companies and determine your available legal options. If any of those companies established a bankruptcy trust, you may also be eligible to file a claim through asbestos trust funds.
Find out if you may qualify for compensation. Our experienced mesothelioma attorneys offer a free, confidential case evaluation and work on contingency. Contact us today to learn which legal options may be available based on your diagnosis and asbestos exposure history.
Table 3. Legal Options for Asbestos-Related Compensation
| Route | What It Is | Who It Fits |
| Lawsuit against asbestos manufacturers | A personal injury case against solvent companies that made or sold asbestos-containing products | Most people diagnosed with asbestos-related peritoneal mesothelioma |
| Trust fund claim | A claim filed with trust funds created by bankrupt asbestos manufacturers | People with asbestos exposure linked to bankrupt companies with established trust funds |
| Wrongful death claim | A legal claim filed by eligible surviving family members after a mesothelioma-related death | Families seeking compensation after losing a loved one |
Statute of Limitations
The statute of limitations is the time limit for filing an asbestos-related claim, and it varies by state. In most states, the filing period begins on the date of diagnosis, not the date of asbestos exposure, because mesothelioma often develops decades after exposure. For wrongful death claims, the deadline typically begins on the date of death.
Although your asbestos exposure may have happened many years ago, waiting to contact an attorney after a diagnosis can affect your ability to pursue compensation. Seeking legal guidance as soon as possible can help you protect your rights and meet important filing deadlines.
Get a Free ConsultationWhy Meirowitz & Wasserberg?
Choosing the right law firm can make a meaningful difference in a mesothelioma case. Meirowitz & Wasserberg focuses on asbestos litigation and has extensive experience representing individuals and families affected by asbestos-related diseases nationwide. Our attorneys investigate each case to identify the source of asbestos exposure and pursue all avenues of compensation.
Representative Firm Achievements
- $18 million verdict involving mesothelioma associated with talcum-powder exposure
- Largest mesothelioma recovery in Massachusetts history involving talc pleurodesis
- More than $32 million recovered in a secondary (take-home) asbestos exposure case
- More than $500 million recovered for injured clients
- Recognized among the top 10 national asbestos filers
- Attorneys who have handled 2,000+ mesothelioma cases
- 30+ years of combined legal experience, including representation in cases declined by other law firms
We represent clients on a contingency-fee basis. Free, confidential case evaluations are available 24 hours a day, 7 days a week, and we offer multilingual intake services in Spanish, Russian, Tagalog and other languages. Meirowitz & Wasserberg serves clients throughout the United States, with offices in New York, New Jersey, Pennsylvania, Illinois, Texas, Florida, California, South Carolina and North Carolina.
“I’ll do my best for you. I’ll treat you like family.” –Daniel Wasserberg
Talk to a mesothelioma attorney today. If you or a loved one has received a peritoneal mesothelioma diagnosis, contact Meirowitz & Wasserberg for a free, confidential case evaluation to determine whether you may be eligible to pursue compensation
Frequently Asked Questions
What is peritoneal mesothelioma?
Peritoneal mesothelioma is a rare and aggressive cancer that develops in the peritoneum, the thin membrane lining the abdomen and covering many abdominal organs. It accounts for approximately 15-20% of all mesothelioma cases, making it the second-most-common type. Asbestos exposure most often causes the disease, although not every patient has a known exposure history.
What are the symptoms of peritoneal mesothelioma?
The most common symptoms of peritoneal mesothelioma include abdominal pain, abdominal swelling caused by fluid buildup (ascites), bloating, unexplained weight loss, nausea, vomiting, fatigue and changes in bowel habits. Because these symptoms resemble many common digestive conditions, doctors often delay diagnoses until they can perform imaging tests and a biopsy.
Is asbestos the only cause of peritoneal mesothelioma?
Although asbestos is the primary known risk factor, some patients have no identifiable history of exposure. Researchers continue to study other possible contributing factors, including prior radiation therapy, inherited genetic changes such as BAP1 alterations and other environmental or molecular mechanisms.
What is the survival rate for peritoneal mesothelioma?
Peritoneal mesothelioma survival has improved significantly with modern treatment. Current reports suggest that approximately 65% of treated patients survive at least 5 years, and carefully selected patients undergoing CRS with HIPEC may achieve even better outcomes. Individual prognoses vary.
What is the life expectancy for peritoneal mesothelioma?
Median life expectancy for treated patients is roughly 31-92 months, although survival varies widely. Patients with epithelioid mesothelioma, a lower PCI score, successful tumor removal and good overall health generally have the most favorable outlook.
What is cytoreductive surgery with HIPEC?
CRS with heated chemotherapy is the standard treatment for many eligible patients with peritoneal mesothelioma. During CRS, surgeons remove all visible tumors. Heated chemotherapy then circulates throughout the abdomen to destroy remaining microscopic cancer cells and reduce the risk of recurrence.
How do doctors determine the stages of peritoneal mesothelioma?
Physicians usually stage peritoneal mesothelioma using the Peritoneal Cancer Index rather than the TNM Classification used for pleural mesothelioma and many other cancers. The PCI measures the size and distribution of tumors throughout the abdomen, helping doctors estimate the scope of the disease and determine whether cytoreductive surgery and HIPEC are appropriate treatment options.
Can I receive compensation for peritoneal mesothelioma?
People diagnosed with asbestos-related peritoneal mesothelioma may be eligible to pursue financial compensation. Depending on the circumstances, legal options may include personal injury lawsuits, asbestos trust fund claims or wrongful death claims for eligible family members. An experienced asbestos attorney can review your diagnosis and exposure history to determine whether compensation may be available.
About The Author
Daniel Wasserberg
Founding Partner
Daniel Wasserberg, a founding partner of Meirowitz & Wasserberg, is a Best Lawyers-recognized and Super Lawyers-rated mesothelioma attorney with over 20 years of experience. Named a Top 100 Trial Lawyer and Top 10 Asbestos-Mesothelioma Lawyer, he leads the firm's national asbestos practice.